Alexandre SIMONIN

Person

Rosenau, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies targeting CD137 and methods of use thereof
- Patent number 12,209,133
- Issue date Jan 28, 2025
- Numab Therapeutics AG
- Tea Gunde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibody comprising CD137 binding domain and PDL1 bin...
- Patent number 12,202,911
- Issue date Jan 21, 2025
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-dimeric multi-specific antibody format targeting at least CD...
- Patent number 12,098,203
- Issue date Sep 24, 2024
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies targeting PDL1 and methods of use thereof
- Patent number 12,077,588
- Issue date Sep 3, 2024
- Numab Therapeutics AG
- Tea Gunde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting CD137 and methods of use thereof
- Patent number 11,578,133
- Issue date Feb 14, 2023
- Namab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD3 antibodies
- Patent number 11,319,371
- Issue date May 3, 2022
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF
- Publication number 20250066482
- Publication date Feb 27, 2025
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS THAT BIND IL-31
- Publication number 20240043547
- Publication date Feb 8, 2024
- Numab Therapeutics AG
- Julia TIETZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION TREATMENT
- Publication number 20230391882
- Publication date Dec 7, 2023
- Numab Therapeutics AG
- David URECH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230203162
- Publication date Jun 29, 2023
- Numab Therapeutics AG
- Peter LICHTLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230192897
- Publication date Jun 22, 2023
- Numab Therapeutics AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20220411536
- Publication date Dec 29, 2022
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20220403028
- Publication date Dec 22, 2022
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF
- Publication number 20210395379
- Publication date Dec 23, 2021
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF
- Publication number 20200332015
- Publication date Oct 22, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF
- Publication number 20200283528
- Publication date Sep 10, 2020
- Numab Therapeutics AG
- Tea GUNDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...
- Publication number 20200181263
- Publication date Jun 11, 2020
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20200115449
- Publication date Apr 16, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY

Alexandre SIMONIN

Person

Patents Grantslast 30 patents

Antibodies targeting CD137 and methods of use thereof

Multispecific antibody comprising CD137 binding domain and PDL1 bin...

Hetero-dimeric multi-specific antibody format targeting at least CD...

Antibodies targeting PDL1 and methods of use thereof

Antibodies targeting CD137 and methods of use thereof

Anti-CD3 antibodies

Patents Applicationslast 30 patents

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

ANTIBODY VARIABLE DOMAINS THAT BIND IL-31

COMBINATION TREATMENT

MULTISPECIFIC ANTIBODY

MULTISPECIFIC ANTIBODY

MULTISPECIFIC ANTIBODY

NOVEL ANTI-CD3 ANTIBODIES

ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF

ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...

NOVEL ANTI-CD3 ANTIBODIES